Schoot, R. A., Bleeker, G., Caron, H. N., van Eck, B. L., Heij, H. A., de Kraker, J., & Tytgat, G. A. (2013). The role of (131)I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma. Springer Berlin Heidelberg.
Chicago Style CitationSchoot, Reineke A., Gitta Bleeker, Huib N. Caron, Berthe L. van Eck, Hugo A. Heij, Jan de Kraker, i Godelieve A. Tytgat. The Role of (131)I-metaiodobenzylguanidine (MIBG) Therapy in Unresectable and Compromising Localised Neuroblastoma. Springer Berlin Heidelberg, 2013.
Cita MLASchoot, Reineke A., et al. The Role of (131)I-metaiodobenzylguanidine (MIBG) Therapy in Unresectable and Compromising Localised Neuroblastoma. Springer Berlin Heidelberg, 2013.
Atenció: Aquestes cites poden no estar 100% correctes.